Identical versus compatible blood typing: investigating best practices in lung transplantation
Transplant International · 22.05.2026 · 39
DOI: 10.3389/ti.2026.15722 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant International, online erschienen am 22.05.2026. Verfasst von Helena Bugacov und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Hauptthemen laut MEDLINE: Lung Transplantation, ABO Blood-Group System, Blood Grouping and Crossmatching. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study investigated acute rejection in ABO-compatible versus ABO-identical lung transplants from 2005–2023, with a secondary objective of comparing 5-year survival. Lung transplantation improves quality of life and survival; however, organ scarcity remains a major challenge. While ABO-identical matching has traditionally been preferred, evolving allocation policies and research have increased the use of ABO-compatible transplants to expand the donor pool. A retrospective cohort study using the UNOS database included adult recipients (n = 32,761). Comparisons were made between ABO-identical (n = 30,347) and ABO-compatible (n = 2,414) groups. Logistic regression assessed acute rejection, and Kaplan-Meier and Cox proportional hazards models evaluated 5-year survival. There was no significant difference in acute rejection (p = 0.99; OR = 1.03, 95% CI 0.86–1.21). ABO-identical transplants showed improved 5-year survival (p = 0.019; HR = 0.91, 95% CI 0.85–0.98), with benefits limited to recipients with obstructive lung disease (p = 0.043) and those in the highest LAS quartile (p = 0.014). The differential benefit of this modest association between ABO-identical matching and survival in this subpopulation remains unclear. Overall, ABO-compatible transplantation safely expands donor availability without increasing rejection risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
- University of California Los Angeles Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, Los Angeles, CA, United States.
- Stevens Institute of Technology School of Business, Hoboken, United States.
Zitieren
APA
Bugacov, H., Cusmai, C., Li, K., Montal, A. M., Dawodu, G., Sun, T., Tuminello, S., Gulati, S., Tseng, K. C., Bernstein, J. T., Laskey, D., Seethamraju, H., & Scheinin, S. (2026). Identical versus compatible blood typing: investigating best practices in lung transplantation. Transplant International, 39. https://doi.org/10.3389/ti.2026.15722
Vancouver
Bugacov H, Cusmai C, Li K, Montal AM, Dawodu G, Sun T, et al. Identical versus compatible blood typing: investigating best practices in lung transplantation. Transplant International. 2026;39. doi:10.3389/ti.2026.15722
BibTeX
@article{Bugacov2026,
author = {Bugacov, Helena and Cusmai, Cristina and Li, Kenneth and Montal, Anne Michelle and Dawodu, Gbalekan and Sun, Tian and Tuminello, Stephanie and Gulati, Shubham and Tseng, Kuo-Chang and Bernstein, Joshua Taylor and Laskey, Daniel and Seethamraju, Harish and Scheinin, Scott},
title = {Identical versus compatible blood typing: investigating best practices in lung transplantation},
journal = {Transplant International},
year = {2026},
volume = {39},
doi = {10.3389/ti.2026.15722}
}
EUVIMED